Meet The Quitters: Perrigo Profiles NRT Users To Help UK Pharmacists Drive OTC Smoking Cessation Sales
To coincide with Stoptober, Perrigo is extending its pharmacy-focused UK marketing strategy for leading smoking cessation brand NiQuitin with research-based sales advice for pharmacists centered on five types of "quitter."
You may also be interested in...
Perrigo is launching in the UK an OTC sildenafil generic to compete with Pfizer's erectile dysfunction drug Viagra Connect.
While lower than results in GSK standard efficacy trial, 'real world' success still is clinically significant, firm's experts tell FDA advisory committee after agency officials asked the panel to consider whether the results translate to clinically meaningful benefit for GSK's proposed mouth spray NRT.
No more than three votes decided the panel's recommendation on each FDA question, and members in the prevailing majorities explained they made their votes with reservations. Potential use by young consumers and confusion by adult users in following the label instructions were primary concerns for all panel members.